How does VisiVite work?
Macular Degeneration treatment was evaluated in the Age Related Eye Disease Study (AREDS), a major study sponsored by the National Eye Institute, one of the Federal government’s National Institutes of Health, and conducted at 11 major medical center research facilities around the country. In that study, ingredients that are identical to those in VisiVite Original Formula were found to slow the progression of macular degeneration in those patients with intermediate or advanced disease. It is believed that the anti-oxidants and Zinc promote the continued health of the retina and tissues surrounding the retina.
